Evaluation of partial β-adrenoceptor agonist activity

British Journal of Clinical Pharmacology

Volumn 43, Issue 1, 1997, Pages 9-14

  Lipworth, Brian J ^a   Grove, Alison ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Asthma; Carteolol; Celiprolol; Exercise; Fenoterol; Partial agonist; Salbutamol; Salmeterol; Adrenoceptor

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARTEOLOL; CELIPROLOL; FENOTEROL; SALBUTAMOL; SALMETEROL;

ADRENERGIC SYSTEM; ANGINA PECTORIS; ASTHMA; EXERCISE; HEART RATE; HUMAN; HYPERKALEMIA; IN VITRO STUDY; IN VIVO STUDY; INTRINSIC SYMPATHOMIMETIC ACTIVITY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0031026316     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1997.tb00130.x     Document Type: Review

References (32)

1. Waller DG. β-adrenoceptor partial agonists: a renaissance in cardiovascular therapy? Br J Clin Pharmacol 1990; 30: 157-171.
2. O'Donnell SR. An examination of some β-adrenoceptor stimulants for selectivity using the isolated trachea and atria of the guinea-pig. EurJ Pharmacol 1972; 19: 371-379.
3. Wilson C, Lincoln C. β-adrenoceptor subtypes in human, rat, guinea-pig and rabbit atria. J Cardiovasc Pharmacol 1984; 6: 1216-1221.
4. O'Donnell SR, Wanstall JC. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol of β-adrenoceptors in guinea-pig trachea. Eur J Pharmacol 1978; 47: 333-340.
5. Linden A, Bergendal A, Ulman A, Skoogh BE, Löfdahl CG. Salmeterol, formoterol and salbutamol in the isolated guineapig trachea: differences in maximum relative effect and potency but not in functional antagonism. Thorax 1993; 48: 547-553.
6. 2-adrenoceptor agonists with higher efficacy on guinea pig trachea and human bronchus in vitro. Br J Pharmacol 1994; 113: 687-692.
7. Molinoff PB, Aarons RD. Effects of drugs on β-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol 1983; 5: 563-567.
8. 2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther 1985; 235: 657-664.
9. 2 adrenoceptors. Eur J Pharmacol 1989; 170: 243-255.
10. Thom TCK, Riddell JG, Shanks RG. The effect of increasing doses of celiprolol on sleeping heart rate and quality of sleep in man. Clin Pharmacol Ther 1991; 49: PIII-54.
11. Wheeldon NM, McDevitt DG, Lipworth BJ. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects. Br J Clin Pharmacol 1992; 34: 337-343.
12. Silke B, Verma SP, Frais MA, Reynolds G, Taylor SH. Comparative effects of metoprolol and celiprolol on cardiac haemodynamics and left ventricular volume at rest and during exercise-induced angina. Clin Pharmacol Ther 1986; 39: 5-14.
13. Svendsen TC, Hartling O, Traup-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI89, 406 in healthy volunteers. Eur J Clin Pharmacol 1979; 15: 223-228.
14. 1-adrenoceptor blocking drug ICI141, 292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease. Br J Clin Pharmacol 1987; 23: 35-40.
15. 1-adrenoceptor partial agonist, in healthy volunteers at rest. Br J Clin Pharmacol 1986; 21: 259-265.
16. Silke B, Thompson A, Leitch A, Riddell JG. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers. Br J Clin Pharmacol 1995; 40: 37-42.
17. 2-agonist activity a dose-ranging study with carteolol. Br J Clin Pharmacol 1992; 33: 411-416.
18. McDevitt DG, Brown HC, Carruthers SG, Shanks RG. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta-adrenoceptor blockade. Clin Pharmacol Ther 1976; 21: 556-566.
19. McCaffrey PM, Riddell JG, Shanks RG. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. Br J Clin Pharmacol 1987; 24: 571-580.
20. Williams ME, Geivinof V, Rosa RM, et al. Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med 1985; 312: 823-827.
21. Svensson A, Gudbrandssen T, Sivertssen R, Haussen L. Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics. Clin Sci 1981; 61: 425s-127s.
22. Forfang K, Simonsen S. Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion. EurJ Clin Pharmacol 1989; 37: 23-27.
23. 1-adrenoceptor partial agonist, ICI118, 587. Eur Heart J 1982; 31(Suppl D): 123-127.
24. Hedner J, Ullman A, Lemne C, Svedmyr N. Effects of dilevalol, or β-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients, Pulm Pharmacol 1989; 2: 155-159.
25. Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso S. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. J Cardiovasc Pharmacol 1986; 8(Suppl 4): S105-S108.
26. Doshan HD, Brown R, Applin WJ, Kapoor M, Caruso S. Effects of high doses ot celiprolol in asthmatic patients. J Cardiovasc Pharmacol 1986; 8(Suppl 4): S109-S111.
27. 2-blocker in propranolol sensitive asthmatic patients. J Cardiovasc Pharmacol 1986; 8 (Suppl. 4): 540-542.
28. Lipworth BJ, Newnham DM, Clark RA, Dhillon DP, Winter JM, McDevitt DG. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax 1995; 50: 54-61.
29. 2-agonists in the management of asthma. Drug Safety 1992; 7: 54-70.
30. 2-adrenoceptor partial agonist/antagonist activity of salbutamol in studies of low and high adrenergic tone. Thorax 1995; 50: 134-138.
31. 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol. Thorax 1996; 51: 54-58.
32. 2 responses to fenoterol. Thorax 1996; 51: 585-589.